Treatment of idiopathic retroperitoneal fibrosis

Bibliography

• Vaglio A, Buzio C. Chronic periaortitis: a spectrum of diseases. Curr Opin Rheumatol 2005;17:34-40
   PubMed Web of Science ®Google Scholar
• Salvarani C, Pipitone N, Versari A, et al. Positron emission tomography (PET): evaluation of chronic periaortitis. Arthritis Rheum 2005;53:298-303
   PubMed Web of Science ®Google Scholar
• Palmisano A, Vaglio A. Chronic periaortitis: a fibro-inflammatory disorder. Best Pract Res Clin Rheumatol 2009;23:339-53
   PubMed Web of Science ®Google Scholar
• Scheel PJ Jr, Feeley N. Retroperitoneal fibrosis. Rheum Dis Clin North Am 2013;39:365-81
   PubMed Web of Science ®Google Scholar
• Kottra JJ, Dunnick NR. Retroperitoneal fibrosis. Radiol Clin North Am 1996;34(6):1259-75
   Google Scholar
• Vaglio A, Palmisano A, Corradi D, et al. Retroperitoneal fibrosis: evolving concepts. Rheum Dis Clin North Am 2007;33:803-17. vi-vii
   Google Scholar
• Kermani TA, Crowson CS, Achenbach SJ, et al. Idiopathic retroperitoneal fibrosis: a retrospective review of clinical presentation, treatment, and outcomes. Mayo Clin Proc 2011;86(4):297-303
   Google Scholar
• Brandt AS, Kamper L, Kukuk S, et al. Associated findings and complications of retroperitoneal fibrosis in 204 patients: results of a urological registry. J Urol 2011;185:526-31
   PubMed Web of Science ®Google Scholar
• Vaglio A. Retroperitoneal fibrosis: new insights into clinical presentation and diagnosis. Medicine (Baltimore) 2009;88:208-10
   PubMed Web of Science ®Google Scholar
• Vaglio A, Salvarani C, Buzio C. Retroperitoneal fibrosis. Lancet 2006;367(9506):241-51
   PubMed Web of Science ®Google Scholar
• Pipitone N, Ghinoi A, Versari A, et al. Images in cardiovascular medicine. Chronic periaortitis. Circulation 2008;118:1214-16
   Google Scholar
• van Bommel EF, Jansen I, Hendriksz TR, et al. Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiologic presentation. Medicine (Baltimore) 2009;88:193-201
   PubMed Web of Science ®Google Scholar
• Vaglio A, Palmisano A, Ferretti S, et al. Peripheral inflammatory arthritis in patients with chronic periaortitis: report of five cases and review of the literature. Rheumatology (Oxford) 2008;47:315-18
   Google Scholar
• Famularo G, Palmisano A, Afeltra A, et al. Retroperitoneal fibrosis associated with psoriasis: a case series. Scand J Rheumatol 2009;38:68-9
   PubMed Web of Science ®Google Scholar
• Palmisano A, Urban M.L, Salvarani C, et al. Chronic periaortitis with thoracic aorta involvement: identification of a new disease subset with deatures of large-vessel vasculitis. 9th international Congress on Autoimmunity; 26 – 30 March 2014; Nice, France
   Google Scholar
• Mahajan VS, Mattoo H, Deshpande V, et al. IgG4-related disease. Annu Rev Pathol 2014;9:315-47
   PubMed Web of Science ®Google Scholar
• Khosroshahi A, Carruthers MN, Stone JH, et al. Rethinking Ormond’s disease: “idiopathic” retroperitoneal fibrosis in the era of IgG4-related disease. Medicine (Baltimore) 2013;92:82-91
   PubMed Web of Science ®Google Scholar
• Zen Y, Fujii T, Harada K, et al. Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology 2007;45:1538-46
   PubMed Web of Science ®Google Scholar
• Kamisawa T, Anjiki H, Egawa N, et al. Allergic manifestations in autoimmune pancreatitis. Eur J Gastroenterol Hepatol 2009;21(10):1136-9
   Google Scholar
• Fairweather J, Jawad AS. Immunoglobulin G4-related retroperitoneal fibrosis: a new name for an old disease. Urology 2013;82:505-7
   Google Scholar
• Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med 2012;366:539-51
   PubMed Web of Science ®Google Scholar
• Scavalli AS, Spadaro A, Riccieri V, et al. Long-term follow-up of low-dose methotrexate therapy in one case of idiopathic retroperitoneal fibrosis. Clin Rheumatol 1995;14:481-4
   Google Scholar
• Scheel PJ Jr, Feeley N, Sozio SM. Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis: a case series. Ann Intern Med 2011;154:31-6
   PubMed Web of Science ®Google Scholar
• Vaglio A, Greco P, Buzio C. Tamoxifen therapy for retroperitoneal fibrosis. Ann Intern Med 2006;144:619; author reply 619-20
   Google Scholar
• Vaglio A, Palmisano A, Alberici F, et al. Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial. Lancet 2011;378:338-46
   PubMed Web of Science ®Google Scholar
• van Bommel EF. Retroperitoneal fibrosis. Neth J Med 2002;60:231-42
   PubMed Web of Science ®Google Scholar
• Mertens S, Zeegers AG, Wertheimer PA, et al. Efficacy and complications of urinary drainage procedures in idiopathic retroperitoneal fibrosis complicated by extrinsic ureteral obstruction. Int J Urol 2014;21:283-8
   Google Scholar
• Klarskov P, Nordling J, Nielsen JB. Experience with Memokath 051 ureteral stent. Scand J Urol Nephrol 2005;39(2):169-72
   PubMed Web of Science ®Google Scholar
• Adamo R, Saad WE, Brown DB. Management of nephrostomy drains and ureteral stents. Tech Vasc Interv Radiol 2009;12:193-204
   Google Scholar
• Ku JH, Lee SW, Jeon HG, et al. Percutaneous nephrostomy versus indwelling ureteral stents in the management of extrinsic ureteral obstruction in advanced malignancies: are there differences? Urology 2004;64:895-9
   PubMed Web of Science ®Google Scholar
• Tiptaft RC, Costello AJ, Paris AM, et al. The long-term follow-up of idiopathic retroperitoneal fibrosis. Br J Urol 1982;54:620-4
   PubMedGoogle Scholar
• Lodde M, Pycha A, Palermo S, et al. Uretero-ureterocutaneostomy (wrapped by omentum). BJU Int 2005;95:371-3
   Google Scholar
• Elashry OM, Nakada SY, Wolf JS Jr, et al. Ureterolysis for extrinsic ureteral obstruction: a comparison of laparoscopic and open surgical techniques. J Urol 1996;156:1403-10
   PubMed Web of Science ®Google Scholar
• Srinivasan AK, Richstone L, Permpongkosol S, et al. Comparison of laparoscopic with open approach for ureterolysis in patients with retroperitoneal fibrosis. J Urol 2008;179:1875-8
   PubMed Web of Science ®Google Scholar
• Arvind NK, Singh O, Ali Q, et al. Laparoscopic ureterolysis and omental wrapping in patients with retroperitoneal fibrosis and obstructive uropathy: a single-center experience. J Laparoendosc Adv Surg Tech A 2014;24:159-64
   Google Scholar
• Fry AC, Singh S, Gunda SS, et al. Successful use of steroids and ureteric stents in 24 patients with idiopathic retroperitoneal fibrosis: a retrospective study. Nephron Clin Pract 2008;108:c213-20
   PubMedGoogle Scholar
• Paz Z, Shoenfeld Y. Antifibrosis: to reverse the irreversible. Clin Rev Allergy Immunol 2010;38:276-86
   PubMed Web of Science ®Google Scholar
• Kardar AH, Kattan S, Lindstedt E, et al. Steroid therapy for idiopathic retroperitoneal fibrosis: dose and duration. J Urol 2002;168:550-5
   PubMed Web of Science ®Google Scholar
• van Bommel EF, Siemes C, Hak LE, et al. Long-term renal and patient outcome in idiopathic retroperitoneal fibrosis treated with prednisone. Am J Kidney Dis 2007;49:615-25
   PubMed Web of Science ®Google Scholar
• Proven A, Gabriel SE, Orces C, et al. Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes. Arthritis Rheum 2003;49:703-8
   PubMed Web of Science ®Google Scholar
• Magrey MN, Husni ME, Kushner I, et al. Do acute-phase reactants predict response to glucocorticoid therapy in retroperitoneal fibrosis? Arthritis Rheum 2009;61:674-9
   Google Scholar
• Marcolongo R, Tavolini IM, Laveder F, et al. Immunosuppressive therapy for idiopathic retroperitoneal fibrosis: a retrospective analysis of 26 cases. Am J Med 2004;116:194-7
   PubMed Web of Science ®Google Scholar
• Vega J, Goecke H, Tapia H, et al. Treatment of idiopathic retroperitoneal fibrosis with colchicine and steroids: a case series. Am J Kidney Dis 2009;53:628-37
   PubMed Web of Science ®Google Scholar
• Benson JR, Baum M. Tamoxifen for retroperitoneal fibrosis. Lancet 1993;341:836
   Google Scholar
• Chau D, Mancoll JS, Lee S, et al. Tamoxifen downregulates TGF-beta production in keloid fibroblasts. Ann Plast Surg 1998;40:490-3
   PubMed Web of Science ®Google Scholar
• Cutolo M, Sulli A, Capellino S, et al. Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. Lupus 2004;13:635-8
   PubMed Web of Science ®Google Scholar
• van Bommel EF, Pelkmans LG, van Damme H, et al. Long-term safety and efficacy of a tamoxifen-based treatment strategy for idiopathic retroperitoneal fibrosis. Eur J Intern Med 2013;24:444-50
   PubMed Web of Science ®Google Scholar
• Scheel PJ Jr, Piccini J, Rahman MH, et al. Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis. J Urol 2007;178:140-3. discussion 3-4
   Google Scholar
• Jois RN, Kerrigan N, Scott DG. Mycophenolate mofetil for maintenance of remission in idiopathic retroperitoneal fibrosis. Rheumatology (Oxford) 2007;46:717-18
   Google Scholar
• Grotz W, von Zedtwitz I, Andre M, et al. Treatment of retroperitoneal fibrosis by mycophenolate mofetil and corticosteroids. Lancet 1998;352:1195
   PubMed Web of Science ®Google Scholar
• Badid C, Vincent M, McGregor B, et al. Mycophenolate mofetil reduces myofibroblast infiltration and collagen III deposition in rat remnant kidney. Kidney Int 2000;58:51-61
   PubMed Web of Science ®Google Scholar
• Kramer S, Loof T, Martini S, et al. Mycophenolate mofetil slows progression in anti-thy1-induced chronic renal fibrosis but is not additive to a high dose of enalapril. Am J Physiol Renal Physiol 2005;289:F359-68
   PubMed Web of Science ®Google Scholar
• Alberici F, Palmisano A, Urban ML, et al. Methotrexate plus prednisone in patients with relapsing idiopathic retroperitoneal fibrosis. Ann Rheum Dis 2013;72:1584-6
   PubMed Web of Science ®Google Scholar
• Catanoso MG, Spaggiari L, Magnani L, et al. Efficacy of infliximab in a patient with refractory idiopathic retroperitoneal fibrosis. Clin Exp Rheumatol 2012;30:776-8
   PubMed Web of Science ®Google Scholar
• Vaglio A, Catanoso MG, Spaggiari L, et al. Interleukin-6 as an inflammatory mediator and target of therapy in chronic periaortitis. Arthritis Rheum 2013;65:2469-75
   PubMedGoogle Scholar
• Maritati F, Corradi D, Versari A, et al. Rituximab therapy for chronic periaortitis. Ann Rheum Dis 2012;71:1262-4
   PubMed Web of Science ®Google Scholar
• Hess JL, Bodis S, Pinkus G, et al. Histopathologic grading of nodular sclerosis Hodgkin’s disease. Lack of prognostic significance in 254 surgically staged patients. Cancer 1994;74:708-14
   PubMed Web of Science ®Google Scholar
• Pickhardt PJ, Bhalla S. Unusual nonneoplastic peritoneal and subperitoneal conditions: CT findings. Radiographics 2005;25:719-30
   Google Scholar
• Ozener C, Kiris S, Lawrence R, et al. Potential beneficial effect of tamoxifen in retroperitoneal fibrosis. Nephrol Dial Transplant 1997;12:2166-8
   Google Scholar
• Coffin CM, Hornick JL, Fletcher CD. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol 2007;31:509-20
   PubMed Web of Science ®Google Scholar
• Dei Tos A. Atypical lipomatous tumor/well differentiated liposarcoma. In: World Health Organisation classification of tumours pathology and genetics of tumours of soft tissue and bone. 2002. p. 35-7
   Google Scholar
• Sakamoto A, Oda Y, Adachi T, et al. Beta-catenin accumulation and gene mutation in exon 3 in dedifferentiated liposarcoma and malignant fibrous histiocytoma. Arch Pathol Lab Med 2002;126:1071-8
   PubMedGoogle Scholar
• Parums DV. The spectrum of chronic periaortitis. Histopathology 1990;16:423-31
   PubMed Web of Science ®Google Scholar
• Mitchinson MJ. The pathology of idiopathic retroperitoneal fibrosis. J Clin Pathol 1970;23:681-9
   PubMed Web of Science ®Google Scholar
• Pipitone N, Vaglio A, Salvarani C. Retroperitoneal fibrosis. Best Pract Res Clin Rheumatol 2012;26:439-48
   PubMed Web of Science ®Google Scholar
• Palmisano A, Corradi D, Carnevali ML, et al. Chronic periaortitis associated with membranous nephropathy: clues to common pathogenetic mechanisms. Clin Nephrol 2010;74:485-90
   PubMed Web of Science ®Google Scholar
• Vaglio A, Corradi D, Manenti L, et al. Evidence of autoimmunity in chronic periaortitis: a prospective study. Am J Med 2003;114:454-62
   PubMed Web of Science ®Google Scholar
• Martorana D, Vaglio A, Greco P, et al. Chronic periaortitis and HLA-DRB1*03: another clue to an autoimmune origin. Arthritis Rheum 2006;55:126-30
   PubMed Web of Science ®Google Scholar